My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Roku Is Worth More As A Takeover Target — Her...
After SpaceX's Nearly $2 Trillion IPO, Is Bez...
Salesforce Puts Money Where Their Mouth Is -...
Micron's Broadcom‑Driven Drop Never Made Sens...
Kalshi's Record $18B Month Was Powered By A S...
SpaceX ETF Race Heats Up, Direxion Among Firs...
Anthropic Is Racing To Save Its Most Advanced...
Rivian Shares Advance As CEO Outlines Aggress...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    EDITAS MEDICINE INC (NASDAQ: EDIT)

    Overview
    current price
    $2.46
    $2.46
    change
    -0.04 | -1.60%
    -0.04 | -1.60%
    Yesterday's Close
    2.50
    open
    2.55
    volume
    2.46 M
    30d. avg volume.
    2.59 M
    1 day
    2.44 - 2.65
    52 weeks
    1.66 - 4.54
    p/e
    0.00
    beta
    2.1624
    market cap
    0.38 B
    dividend yield
    0.00%
    Industry
    -
    EDIT by TradingView
    News and Commentary
    Profile: Cathie Wood Every bull market seems to bring a new superstar fund manager to the forefront. During the 90s and early 2000s, Bill Miller was highly touted due to his aggressive bets on financ...
    Gene Editing Stocks Could Power Next Leg of Biotech Bull Market Since this current bull market began in March 2009, one of the leading sectors has been biotech stocks
    Ipo weekly update. It was a 50/50 week for IPO's last week and considering the deal size of the two that didn't list, we think it's still looking good for new issues. The two biotech companies that...
    IPO markets showing consistency. Three companies raised $639 million last week which ties the prior week as the year's most active by deal count. Even though all three companies pay dividends, and the IPO market...
    A good start for 2016 IPO’s The first IPO's of 2016 hit the market this week and both were biotech company's. Although 81% of all 2015 biotech IPO's trade below opening price, the first two for 2016 are off...
    On to February! Well December 2015 was the slowest month for IPO's since 2008 and one would have thought that it couldn't get any worse. Well, then I have bad news for you. With no IPO's coming...
    Monday's IPO Review The IPO markets continue their slumber. Normally the media would pounce on this lack of excitement but with the market volatility the IPO market gets a pass. In fact, if any deal...
    StockTwits
    StockTwits
    Most Shared
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Best Buy Stock Pops After Strong Comparable Sales, Margin Growth
    US Says China To Buy At Least $17 Billion Worth Agricultural Goods Annually After Trump-Xi Meet
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    The AI Spending Boom Just Got Bigger: Goldman Sees $800 Billion Flowing In This Year
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?